Loading...

Brem, Elizabeth A

Title(s)Assistant Health Sciences Professor, Medicine
Phone(714) 456-5153
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Sarkissian S, Khan Y, Farrell D, Constable D, Brem E. Hemophagocytic lymphohistiocytosis in the setting of HELLP Syndrome. Clin Case Rep. 2018 Dec; 6(12):2466-2470. PMID: 30564350.
      View in: PubMed
    2. Robertson JJ, Brem E, Koyfman A. The Acute Hemolytic Anemias: The Importance of Emergency Diagnosis and Management. J Emerg Med. 2017 Aug; 53(2):202-211. PMID: 28408234.
      View in: PubMed
    3. Brem EA, Letai A. BOK: Oddball of the BCL-2 Family. Trends Cell Biol. 2016 06; 26(6):389-390. PMID: 27156889.
      View in: PubMed
    4. Brem EA, Davids MS. Is Bcl-2 a valid target in the treatment of indolent non-Hodgkin lymphoma? Leuk Lymphoma. 2014 Dec; 55(12):2675-7. PMID: 24794805.
      View in: PubMed
    5. Brem E, Koyfman A, Foran M. Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians. J Emerg Med. 2013 Jul; 45(1):143-9. PMID: 23375217.
      View in: PubMed
    6. Brem EA, Thudium K, Khubchandani S, Tsai PC, Olejniczak SH, Bhat S, Riaz W, Gu J, Iqbal A, Campagna R, Knight J, Mavis C, Hoskin P, Deeb G, Gibbs JF, Fetterly G, Czuczman MS, Hernandez-Ilizaliturri FJ. Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas. Br J Haematol. 2011 Jun; 153(5):599-611. PMID: 21492126; PMCID: PMC3092002.